The major dermatomyositis‐specific mi‐2 autoantigen is a presumed helicase involved in transcriptional activation

Wiley - Tập 38 Số 10 - Trang 1389-1399 - 1995
H. P. Seelig1, Isabelle Moosbrugger1, H. Ehrfeld1, Thomas Fink1, Manfred Renz1, E. Genth2
1Institute of Immunology and Molecular Genetics, Karlsruhe, Germany
2Clinic for Rheumatic Diseases, Aachen, Germany

Tóm tắt

AbstractObjective. To characterize the complementary DNA (cDNA) and protein sequences of autoantigens recognized by anti–Mi‐2 antibodies, using recombinant Mi‐2 proteins for improved autoantibody detection.Methods. A cDNA expression library was immunoscreened, and cDNA isolation, alignment, and sequence analysis were performed. Northern blotting and in situ hybridization techniques were used. A recombinant protein (rMi‐2) was synthesized. Immunoprecipitation of 35S‐methionine–labeled HEp‐2 cell proteins and immunoblotting of rMi‐2 and natural nuclear proteins were performed. Immunofluorescence studies were done with anti–Mi‐2 positive sera of dermatomyositis (DM) patients, and with human or rabbit antibodies specific for rMi‐2. Antibody screening of systemic lupus erythematosus, rheumatoid arthritis, DM, and antinuclear antibody–positive human sera was performed using an rMi‐2 protein enzyme‐linked immunosorbent assay (ELISA).Results. A major antigen recognized by anti–Mi‐2 positive sera of DM patients was found to constitute a 218‐kd nuclear protein (218‐kd Mi‐2) encoded on chromosome 12 and to belong to the SNF2/RAD 54 helicase family. Human and rabbit antibodies that were affinity purified using the recombinant protein reacted with and precipitated a nuclear protein of similar size, which was also recognized by anti–Mi‐2 sera. Anti–218‐kd Mi‐2 antibodies detected by rMi‐2 protein ELISA seemed to be mainly restricted to sera from patients with DM.Conclusion. The molecular characterization of the 218‐kd Mi‐2 antigen may contribute to our understanding of autoimmune phenomena in DM. The use of immunoreactive recombinant proteins allows structural and functional studies of the helicase and the development of sensitive and accurate antibody screening tests.

Từ khóa


Tài liệu tham khảo

10.1016/0090-1229(76)90145-8

10.1016/0161-5890(80)90109-1

Targoff IN, 1983, Antibodies to Mi‐1 in SLE: relationship to other precipitins and reaction with bovine immunoglobulin, Clin Exp Immunol, 53, 76

10.1056/NEJM197502132920706

10.1002/art.1780280711

Targoff IN, 1990, Clinical features and immunologic testing of patients with anti‐Mi‐2 antibodies (abstract), Arthritis Rheum, 33, S72

Targoff IN, 1993, Humoral immunity in polymyositis/dermatomyositis, J Invest Dermatol, 100, 116S, 10.1038/jid.1993.34

10.1097/00005792-199111000-00002

10.1002/art.1780371019

10.1002/art.1780380119

10.1002/art.1780371117

10.1007/BF00302148

Seelig HP, 1992, Antibodies to recombinant U1‐70K, U1‐A and U1‐C protein in SLE patients and relatives (abstract), Clin Rheumatol, 11, 132

10.1002/art.1780251101

10.1002/art.1780230510

10.1002/art.1780310302

Harlow E, 1988, Antibodies: A Laboratory Manual

10.1073/pnas.85.23.8998

10.1016/0003-2697(83)90418-9

10.1016/S0022-2836(05)80360-2

10.1093/nar/19.suppl.2241

10.1073/pnas.78.11.6633

10.1126/science.2294592

Lichter P, 1992, Human Cytogenetics

10.1016/0076-6879(90)85008-C

10.1016/0022-1759(91)90267-J

10.1016/S0021-9258(18)54860-2

10.1093/nar/21.3.751

10.1093/nar/17.12.4713

10.1073/pnas.88.23.10647

10.1002/j.1460-2075.1982.tb01276.x

10.1002/j.1460-2075.1992.tb05330.x

10.1073/pnas.84.6.1472

10.1093/nar/17.3.1197

10.1073/pnas.83.12.4399

10.1007/BF00291737

10.1021/bi00400a004

10.1093/nar/22.22.4566

10.1126/science.7801121

10.1016/0092-8674(94)90227-5

10.1093/nar/20.17.4649

10.1073/pnas.88.7.2687

10.1038/366170a0

10.1016/0092-8674(92)90192-F

Thông tin
Thông tin xuất bản

Wiley

Tập 38 Số 10

1389-1399

Thông tin tác giả